Top Markets
Coin of the day
Algorae Pharmaceuticals Limited Algorae Pharmaceuticals Limited

Algorae Pharmaceuticals Limited

1AI
Classifica tra le azioni #30360
Algorae Pharmaceuticals Limited, a company established in 1987 and based in... Algorae Pharmaceuticals Limited, a company established in 1987 and based in Melbourne, Australia, focuses on pioneering pharmaceutical development. Known as Living Cell Technologies Limited until its rebranding in September 2023, the firm primarily conducts research and innovation in living cell technologies within New Zealand. Its development portfolio includes AI-116, a novel combination treatment pairing donepezil with cannabidiol, designed to address various forms of dementia, such as Alzheimer's disease. Another key candidate is AI-168, a unique blend of a cannabinoid and an existing, off-patent drug component, aimed at managing cardiovascular conditions like hypertension. Additionally, Algorae is progressing with NTCELL, an alginate-encapsulated product for the treatment of Parkinson's disease. The company is also collaborating with the University of New South Wales to create AlgaraeOS, an advanced drug discovery platform that utilizes artificial intelligence protocols and extensive data analytics to optimize drug identification and development processes.
Prezzo delle azioni
$0.00846342
Capitalizzazione di mercato
$17.16M
Variazione (1 giorno)
9.09%
Variazione (1 anno)
87.30%
Paese
AU
Scambia Algorae Pharmaceuticals Limited (1AI)

Categoria

Storico del prezzo dell'azione per Algorae Pharmaceuticals Limited (1AI)
Prezzo di chiusura più alto: $0.01 il 2026-08-01

Prezzo di chiusura più basso: $0.01 il 2023-08-01
Storico del prezzo dell'azione di Algorae Pharmaceuticals Limited dal 2023 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) -10.71%
2025 104.60%
2024 -39.97%
2023 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$527.89 35.09%
US
$996.61 51.72%
NL
$116.54 -19.94%
AU
$735.86 6.07%
CH
$257.75 14.92%
BE